Takotsubo Syndrome Triggered by Immune Checkpoint Inhibitor-Induced Pneumonitis: A Multidisciplinary Diagnostic and Therapeutic Challenge

Marco Kaldas; Moneal Shah; Valentyna Ivanova; Saed Alnaimat; Diana Pashaieva; Ronald Williams; Anita Radhakrishnan

doi:10.12659/AJCR.950756

29 January 2026 : Case report USA

Takotsubo Syndrome Triggered by Immune Checkpoint Inhibitor-Induced Pneumonitis: A Multidisciplinary Diagnostic and Therapeutic Challenge

Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Rare disease, Adverse events of drug therapy, Clinical situation which can not be reproduced for ethical reasons

Marco Kaldas^{ABDE 1,2*}, Moneal Shah^{DF 1}, Valentyna Ivanova^{ADF 1}, Saed Alnaimat

^{E 1}, Diana Pashaieva^{CG 2}, Ronald Williams^{B 1}, Anita Radhakrishnan^{ADEF 1}

DOI: 10.12659/AJCR.950756

Am J Case Rep 2026; 27:e950756

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 CMR T2-weighted imaging showing myocardial edema in apical segments.

Back to the Article

Takotsubo Syndrome Triggered by Immune Checkpoint Inhibitor-Induced Pneumonitis: A Multidisciplinary Diagnostic and Therapeutic Challenge

Your Privacy